← SynDRA
RAPACURONIUM
SynDRA canonical compound SYN0023553 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | CHRM2 |
|---|
| Mechanism of action | acetylcholine receptor antagonist |
|---|
| Indication | general anaesthetic |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- CHRM2
- CHRNA1
- CHRNB1
- CHRND
- CHRNE
- CHRNG
Mechanisms of action (all sources)
- acetylcholine receptor antagonist
- CHRNA1 ANTAGONIST
- CHRNG ANTAGONIST
- CHRNB1 ANTAGONIST
- CHRNE ANTAGONIST
- CHRND ANTAGONIST
Drug classes
- Neuromuscular Agents
- Neuromuscular Blocking Agents
- Neuromuscular Nondepolarizing Agents
- Peripheral Nervous System Agents
Cross-references
Synonyms
- Org 9487
- Org9487
- rapacuronium bromide
- raplon
- Rapacuronium cation
- Rapacuronium ion
- GG1LBM463S
- RefChem:178638
- DTXCID501509816
- UNII-GG1LBM463S
- NCGC00183839-01
- RAPACURONIUM [VANDF]
- SCHEMBL16977930
- CHEBI:135845
- NS00069634
- [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-acetyloxy-10,13-dimethyl-2-piperidin-1-yl-16-(1-prop-2-enylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate
- bromuro de rapacuronio
- UNII-65Q4QDG4KC
- Raplon
- EBC-102161
- RAPACURONIUM BROMIDE [ORANGE BOOK]
- D05703
- Tox21_113304
- DA-77347
- Raplon (TN)
- Rapacuronium bromide [USAN:INN:BAN]
- C37H61BrN2O4
- RAPACURONIUM BROMIDE [MART.]
- CAS-156137-99-4
- T12690
- ORG-9487
- RAPACURONIUM BROMIDE [VANDF]
- MFCD00870871
- DTXCID0028749
- G12807
- RAPACURONIUM BROMIDE [WHO-DD]
- ORG9487
Look up RAPACURONIUM in the interactive SynDRA portal →